In studies in aging mice, ginsenoside Rg1 reduced NOX4, NF-κB, NLRP3 inflammatory expression levels, thereby improving aging-induced liver fibrosis [230]. The gene discussed is NLRP3; the disease is Hepatic fibrosis.